Reliability of IUS in Crohn's Disease (LOTUS)

Centre Hospitalier Universitaire, Amiens

Status: Enrolling

Conditions: Crohn Disease (CD)

Treatments: Other: Transabdominal intestinal ultrasound

Study type: Interventional

Funder types: Other

Identifiers

NCT06833450

PI2022_843_0006

Details and patient eligibility

About

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD).

In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Crohn's disease evolving for at least 1 months
• Patient older than 18 years
• Patient covered by French national health insurance
• Written informed consent

Exclusion criteria

• Pregnant women or breastfeeding
• Minor
• Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)